Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

A protein found in safflower seeds can stimulate hair growth and speed up wound healing in mice.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Female pattern hair loss greatly harms women's mental health and social life.

Cortisol increases a specific protein in bone cells, which may help explain its negative effects on bone.

Female pattern hair loss may indicate metabolic issues and increased cardiovascular risk.

The conclusion is that hair transplant surgery should use microscopically dissected natural hair groupings and some new terms were suggested for clarity.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Allopregnanolone changes gene expression in glioblastoma cells.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Ferrous Ferric Chloride may improve skin cell function and increase hair growth in mice.

Low SHBG levels are linked to negative health outcomes and should be used in assessing and managing health conditions.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

The free androgen index varies among women with different types of PCOS.

The material improved facial wrinkles and skin appearance.

Retinoic acid, glucocorticoids, and IGF1 increase IGFBP-3 production in human dermal papilla cells, affecting hair growth.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Growth factor treatments are increasingly used in medicine but require more research to fully understand their mechanisms.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Metabolic processes and key genes like FGF5, FGFR1, and RRAS significantly affect hair follicle growth in Inner Mongolian Cashmere goats.

Oleuropein increases IGF-1 levels in mouse skin.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

TGF-β1 and 2 may play a role in hair loss in AGA.